The experimental TASK-1 potassium channel inhibitor A293 can be employed for rhythm control of persistent atrial fibrillation in a translational large animal model

April 16, 2021 2:33 pm Published by

Wiedmann F, Beyersdorf C, Zhou X-B, Kraft M, Foerster KI, El-Battrawy I, Lang S, Borggrefe M, Haefeli WE , Frey N, Schmidt C. The experimental TASK-1 potassium channel inhibitor A293 can be employed for rhythm control of persistent atrial fibrillation in a translational large animal model. Front Physiol 2021/11:629421. doi: 10.3389/fphys.2020.629421.

Categorised in:

This post was written by sfb1425